Last reviewed · How we verify
Local anesthesia at incision site — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Local anesthesia at incision site (Local anesthesia at incision site) — The University of Texas Health Science Center, Houston.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Local anesthesia at incision site TARGET | Local anesthesia at incision site | The University of Texas Health Science Center, Houston | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Local anesthesia at incision site CI watch — RSS
- Local anesthesia at incision site CI watch — Atom
- Local anesthesia at incision site CI watch — JSON
- Local anesthesia at incision site alone — RSS
Cite this brief
Drug Landscape (2026). Local anesthesia at incision site — Competitive Intelligence Brief. https://druglandscape.com/ci/local-anesthesia-at-incision-site. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab